|
PROLONGATION OF QT INTERVAL MAY BE SERIOUS COMPLICATION
|
CO-ADMINISTRATION WITH AN ALUMINIUM AND MAGNESIUM CONTAINING ANTACID RESULTED IN A REDUCTION IN PLASMA CELECOXIB CONCENTRATION WITH A DECREASE OF 37% IN CMAX AND 10% IN AUC
|
CO-ADMINISTRATION WITH AN ALUMINIUM AND MAGNESIUM CONTAINING ANTACID RESULTED IN A REDUCTION IN PLASMA CELECOXIB CONCENTRATION WITH A DECREASE OF 37% IN CMAX AND 10% IN AUC
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
TRANSIENT ELEVATIONS IN SERUM CREATININE
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
DIDANOSINE SHOULD BE TAKEN 2 HRS AFTER OR 6 HRS BEFORE QUINOLONES LIKE CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CO-ADMINISTRATION WITH SUCRALFATE MAY SUBSTANTIALLY INTERTERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE TAKEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH ZINC-CONTAINING PRODUCTS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE TAKEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH ZINC-CONTAINING PRODUCTS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE TAKEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH ZINC-CONTAINING PRODUCTS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE TAKEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH ZINC-CONTAINING PRODUCTS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE TAKEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|